The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.
about
The Need for Pediatric Formulations to Treat Children with HIVSurvival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern MalawiMedicines shortages-unpicking the evidence from a year in South AfricaAdvance market commitment for pneumococcal vaccines: putting theory into practice.An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.Pharmacotherapy of pediatric HIV infectionPediatric treatment 2.0: ensuring a holistic response to caring for HIV-exposed and infected children.PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges.Five-year trends in antiretroviral usage and drug costs in HIV-infected children in ThailandAntiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.High risk of loss to follow-up among South African children on ART during transfer, a retrospective cohort analysis with community tracing.Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.Shortages of medicines: a complex global challenge.Treatment of childhood tuberculosis: caregivers' practices and perceptions in Cape Town, South Africa.Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients.
P2860
Q26740369-C1095181-01BC-42CD-8FE8-1452AFE3D1E0Q28553184-22B5517F-93C7-4D2F-9704-773DB7900F7BQ33732967-A67EB8A6-9E20-4BCB-BE75-2DE0922BEFA2Q35679662-EFB8B5A2-C35E-4293-8F5A-E13FB0D1418EQ35958603-B31C47BD-D7DD-4132-B45D-7863E10FC697Q36301325-79C6BC52-CBA6-4107-8338-3CF3DDB696D8Q36379673-B6AE78A5-B3BC-46FB-BA99-807490A68809Q37087787-CDF31CDA-2B62-4484-9575-54FBC3C6B33FQ37098285-3D38D34D-E576-483E-9BFB-179C707988CAQ37866289-489876F9-0BD7-400B-B242-A0C4D90FC1FBQ37976848-817AF97D-D109-41A4-9C9E-BA52171161D5Q38686944-49A5E800-524B-4A4D-AD71-C19E8FD6E611Q38819654-0E94F485-566B-4193-A36C-87670A54841AQ42563777-2A404BFB-0DF5-4BB1-B2BD-926FCF667FFFQ50465481-983AD369-3DCA-4217-8162-5A37199D6CD2Q53835112-4963B230-9AC5-491F-A92B-A44821B4DA0E
P2860
The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The global pediatric antiretro ...... IV/AIDS treatment in children.
@ast
The global pediatric antiretro ...... IV/AIDS treatment in children.
@en
type
label
The global pediatric antiretro ...... IV/AIDS treatment in children.
@ast
The global pediatric antiretro ...... IV/AIDS treatment in children.
@en
prefLabel
The global pediatric antiretro ...... IV/AIDS treatment in children.
@ast
The global pediatric antiretro ...... IV/AIDS treatment in children.
@en
P2093
P2860
P356
P1433
P1476
The global pediatric antiretro ...... IV/AIDS treatment in children.
@en
P2093
Ellen Diedrichsen
Elodie Jambert
Mieke Pouw
Suerie Moon
P2860
P2888
P356
10.1186/1471-2431-10-74
P577
2010-10-17T00:00:00Z
P5875
P6179
1024126760